Cencora Price to Free Cash Flow Ratio 2010-2023 | COR
Historical price to free cash flow ratio values for Cencora (COR) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cencora Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-04-22 | 236.85 | 13.29 | |
| 2023-12-31 | 204.93 | $17.82 | 11.50 |
| 2023-09-30 | 179.11 | $16.88 | 10.61 |
| 2023-06-30 | 191.02 | $13.52 | 14.13 |
| 2023-03-31 | 158.48 | $11.79 | 13.44 |
| 2022-12-31 | 163.52 | $9.81 | 16.67 |
| 2022-09-30 | 133.12 | $10.45 | 12.74 |
| 2022-06-30 | 138.75 | $9.81 | 14.14 |
| 2022-03-31 | 151.27 | $13.60 | 11.12 |
| 2021-12-31 | 129.51 | $10.35 | 12.51 |
| 2021-09-30 | 115.98 | $10.69 | 10.85 |
| 2021-06-30 | 110.76 | $12.58 | 8.81 |
| 2021-03-31 | 113.79 | $6.47 | 17.58 |
| 2020-12-31 | 93.82 | $12.84 | 7.31 |
| 2020-09-30 | 92.64 | $9.15 | 10.12 |
| 2020-06-30 | 95.93 | $5.98 | 16.04 |
| 2020-03-31 | 83.84 | $9.29 | 9.03 |
| 2019-12-31 | 80.19 | $8.10 | 9.90 |
| 2019-09-30 | 77.30 | $9.61 | 8.05 |
| 2019-06-30 | 79.68 | $9.48 | 8.40 |
| 2019-03-31 | 73.94 | $10.45 | 7.07 |
| 2018-12-31 | 68.86 | $7.07 | 9.74 |
| 2018-09-30 | 84.97 | $4.92 | 17.29 |
| 2018-06-30 | 78.23 | $8.05 | 9.71 |
| 2018-03-31 | 78.74 | $3.10 | 25.41 |
| 2017-12-31 | 83.54 | $6.95 | 12.01 |
| 2017-09-30 | 74.93 | $4.68 | 16.00 |
| 2017-06-30 | 85.20 | $4.16 | 20.48 |
| 2017-03-31 | 79.44 | $6.05 | 13.13 |
| 2016-12-31 | 69.90 | $6.54 | 10.70 |
| 2016-09-30 | 71.89 | $12.01 | 5.99 |
| 2016-06-30 | 70.32 | $12.84 | 5.47 |
| 2016-03-31 | 76.38 | $16.42 | 4.65 |
| 2015-12-31 | 91.17 | $16.02 | 5.69 |
| 2015-09-30 | 83.21 | $16.95 | 4.91 |
| 2015-06-30 | 92.89 | $14.01 | 6.63 |
| 2015-03-31 | 99.05 | $12.12 | 8.18 |
| 2014-12-31 | 78.33 | $13.43 | 5.83 |
| 2014-09-30 | 66.94 | $5.10 | 13.13 |
| 2014-06-30 | 62.73 | $1.52 | 41.26 |
| 2014-03-31 | 56.43 | $-0.36 | 0.00 |
| 2013-12-31 | 60.28 | $-0.73 | 0.00 |
| 2013-09-30 | 52.21 | $2.49 | 20.98 |
| 2013-06-30 | 47.36 | $4.84 | 9.78 |
| 2013-03-31 | 43.47 | $5.05 | 8.61 |
| 2012-12-31 | 36.32 | $1.83 | 19.83 |
| 2012-09-30 | 32.39 | $4.56 | 7.10 |
| 2012-06-30 | 32.82 | $3.82 | 8.60 |
| 2012-03-31 | 32.96 | $4.22 | 7.80 |
| 2011-12-31 | 30.79 | $5.65 | 5.45 |
| 2011-09-30 | 30.75 | $3.65 | 8.43 |
| 2011-06-30 | 34.06 | $4.19 | 8.12 |
| 2011-03-31 | 32.46 | $4.07 | 7.97 |
| 2010-12-31 | 27.92 | $3.00 | 9.29 |
| 2010-09-30 | 25.00 | $3.25 | 7.70 |
| 2010-06-30 | 25.82 | $2.51 | 10.31 |
| 2010-03-31 | 23.46 | $3.13 | 7.51 |
| 2009-12-31 | 21.09 | $1.82 | 11.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.702B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.512B | 15.50 |
| ICON (ICLR) | Ireland | $23.778B | 23.45 |
| DiDi Global (DIDIY) | China | $21.472B | 0.00 |
| Avantor (AVTR) | United States | $16.347B | 22.52 |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| CochLear (CHEOY) | $13.392B | 0.00 | |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.462B | 0.00 |
| Revvity (RVTY) | United States | $12.459B | 21.69 |
| Charles River Laboratories (CRL) | United States | $11.682B | 21.29 |
| Medpace Holdings (MEDP) | United States | $11.526B | 41.89 |
| Solventum (SOLV) | United States | $10.730B | 0.00 |
| Natera (NTRA) | United States | $10.298B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.940B | 51.85 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.595B | 34.21 |
| Organon (OGN) | United States | $4.555B | 4.41 |
| PACS (PACS) | United States | $3.551B | 0.00 |
| Progyny (PGNY) | United States | $3.143B | 52.74 |
| Sotera Health (SHC) | United States | $3.100B | 15.21 |
| Surgery Partners (SGRY) | United States | $3.017B | 28.03 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.643B | 133.80 |
| Premier (PINC) | United States | $2.538B | 9.29 |
| Agilon Health (AGL) | United States | $2.244B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.198B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.158B | 6.98 |
| BrightSpring Health Services (BTSG) | United States | $1.799B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.301B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.301B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.983B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.611B | 4.04 |
| InnovAge Holding (INNV) | United States | $0.537B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.519B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.59 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| CareDx (CDNA) | United States | $0.430B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| LifeMD (LFMD) | United States | $0.392B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.388B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 59.50 |
| Sera Prognostics (SERA) | United States | $0.316B | 0.00 |
| ModivCare (MODV) | United States | $0.302B | 4.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.263B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Sharecare (SHCR) | United States | $0.235B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.115B | 38.67 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |